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Deep generative networks are an emerging technology in drug discovery. Our work
is divided in two parts. In the first one, we built a variational autoencoder (VAE) that
is able to learn the grammar of the molecules, represent them in a latent space, and
generate new ones. In the second one, we built and trained a conditional variational
autoencoder (CVAE) that is capable of generating new molecules based on desired
properties. We will see in detail the architecture of both models and how they were
trained.
The molecule properties were provided by the Chemical Checker (CC), a resource
of processed, harmonised and integrated small-molecule bioactivity data. We will gen-
erate different molecules with different target properties, and we will check how close
the properties of the generated molecules are from the target ones. These properties
are called signatures.
At the end of the project we sample CC signatures with different similarity to the
input molecule signatures, and we show that the signatures of the molecules generated
this way resemble the sampled signatures, meaning that we can generate new random
molecules based on desired properties.
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The chemical space remains mostly unexplored. This means that it is possible to
discover molecules never found before. On the other hand, not all molecules are
feasible. Actually, only a small proportion of the theoretically possible 1060 drug-like
molecules are therapeutically relevant, fact that makes the drug discovery process very
difficult [1, 2]. Therefore, it is necessary to learn the rules of chemistry by analysing
existing chemical matter.
De novo small molecule generation is a re-emerging field thanks to deep learning.
Despite deep learning is not new, the new powerful distributed GPU-based systems
have given a second chance to the field.
Recently, at Institut de Recerca Biomèdica de Barcelona (IRB), they have assem-
bled the Chemical Checker (CC) [3], a large repository of bioactivity data for small
molecules. The CC contains enough information to learn systematically the determi-
nants of a large spectrum of activities. Due to it is possible to learn these determinants,
there is the opportunity to generate new molecules with the desired bioactivities.
There are two main reasons to use these determinants: We want to generate
molecules with the desired bioactivities, and, since the chemical space is unattainable,
we need to do an efficient exploration of it in order to optimise resources and accelerate
the drug discover pipeline.
Although many attempts have been done in the field of de novo molecule generation
[4, 5, 6, 7, 8, 9], we were very eager to try out the CC bioactivity data as input of a
conditional variational autoencoder.
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1.2 Problem statement
The main goal is to generate small de novo molecules with the desired properties,
which, in our case, are the CC signatures (explained in Section 2.2).
Since we are going to work with a neural network, we have to find a molecular
representation that can be understood by the network (SMILES, section 2.1).
We need to find and tune a good model that is able to generate new molecules. In
order to do so, the model has to learn the "grammar" of the molecules. We need to
check if the molecules we are generating are valid or not, and if so, a way to compare
the similarity between the generated molecules and their respective input molecule.
As next step, we will have to expand the model so it can take into account the
properties of the molecule. Once the model is trained, we should be able to generate
new molecules that target specific properties. We also need a way to check if the
generated molecules have properties that are similar to our target.
On top of that, we need to be able to generate molecules that are in the region
of interest in an efficient way, this is, that the ratio of those "interesting" generated






In order to be fed to the algorithm, the molecules have to be processed as a sequence
of characters. This is the case for the Simplified Molecular-Input Line-Entry System
(SMILES) representation, which has been used in several generative algorithms [10].
Each molecule can be represented in different ways using the SMILES notation,
but we will use what is called the canonical version of the smiles, which is unique for
every molecule (see Figure 2.1).
2.2 Signatures
Recently, the Structural Bioinformatics and Network Biology (SBNB) laboratory, led
by Dr. Patrick Aloy at IRB Barcelona, developed the Chemical Checker (CC) [3]. The
CC is a resource of processed, harmonised and integrated small-molecule bioactivity
data. The resource divides data into five levels of increasing complexity, ranging from
the chemical properties of the compounds to their clinical outcomes. In between,
it considers targets, off-targets, perturbed biological networks and several cell-based
assays such as gene expression, growth inhibition and morphological profiles.
Figure 2.1: Caffeine molecule represented as a SMILES
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The main assets of the CC are the so-called "bioactivity signatures". CC signatures
are 128-dimensional vectors (embeddings) that encapsulate data of a certain kind by
means of a two-step algorithm consisting, first, on the calculation of small-molecule
similarities based on bioactivity data, followed by a network-embedding procedure
performed on the resulting small-molecule similarity network. In this work, we capi-
talise on "binding" CC signatures, which embed physical interaction (binding) profiles
of small molecules across a panel of >3,000 proteins.
We will use these signatures in the second model we implemented, and we will
generate random molecules that would satisfy a particular signature as a constraint,
i.e. molecules that would have a binding profile of interest.
2.3 Type of autoencoders
In this section we will present 3 different architectures of autoencoders, starting with
the most simple one and introducing new changes that will adapt the network to our
needs.
2.3.1 Autoencoder
Autoencoders (Figure 2.2) are a special type of neural network architecture in which
the output is the same as the input. Autoencoders are trained in an unsupervised
manner in order to learn low level representations of the input data (encoder). These
low level features are then deformed back to project the actual data (decoder). An
autoencoder is a regression task where the network is asked to predict its input (in
other words, model the identity function). These networks have a tight bottleneck
of a few neurons in the middle, forcing them to create effective representations that
compress the input into a low-dimensional code that can be used by the decoder to
reproduce the original input1.
The encoded representation of the input is a dense vector or a fixed size which is
called latent space. This latent space represents the lowest level space in which the
input is reduced and information is preserved.
1Source: Kaggle
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Figure 2.2: Structure of an autoencoder
Figure 2.3: Structure of a variational autoencoder (VAE)
2.3.2 Variational autoencoder
On the other hand, autoencoders have a drawback: they cannot be used to generate
new data. Introducing the variational autoencoder (VAE), a modified version of the
regular autoencoder. Instead of just learning a function representing the data, they
learn the parameters of a probability distribution (Gaussian for instance) representing
the data. Since it learns to model the data, we can then sample from the distribution
and generate new input data samples2.
As it can be seen in figure 2.3, the structure of the VAE is very similar to the
2Source: Quora
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regular autoencoder, with the difference that this time we have a couple of fully-
connected layers prior to the latent layer. Those two layers are learning the probability
distribution of this latent space, this is, the mean µ and variance σ.
In order to be able to keep the Gaussian shape of the latent space we have to
penalise the network for creating latent spaces that are far from that distribution.
This is done by just adding another term to the current loss function. This term is
the so called Kullback-Leibler divergence (KL divergence). The KL divergence (also
called relative entropy) is a measure of how one probability distribution is different
from a second, reference probability distribution3.
Essentially, what we are looking at with the KL divergence is the expectation of
the log difference between the probability of data in the original distribution with the
approximating distribution.
DKL(p||q) = E[log p(x)− log q(x)] (2.1)








where DKL is The Kullback-Leibler divergence, p is the original distribution and
q our approximating distribution.
2.3.3 Conditional variational autoencoder
So far, we have a generative model able to generate random samples from the latent
space that resemble the input. The decoder cannot, however, produce a sample based
on a particular condition on demand. Enter the conditional variational autoencoder
(CVAE). This architecture has an extra input to both the encoder and the decoder.
This additional input can be, for example, the label of the image you want to decode,
or the properties of the molecule you are trying to reconstruct (which is our case).
By doing this, the neural network stops learning the properties of the condition
we are already providing as second input, and focuses on other properties of the main
input. This allows us not only to sample new data from the latent space, but also to
specify the properties we want to have. For example, in the case of the MNIST dataset
(in which the inputs are images of hand written numbers) the condition would be the
3Source: https://www.countbayesie.com/blog/2017/5/9/kullback-leibler-divergence-explained
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Figure 2.4: Structure of a conditional variational autoencoder
(CVAE)
number itself one-hot encoded. Once the model is trained we can generate images of
a specific number, by just random sampling from the latent space and concatenating
it to the one-hot vector of the number we want.
The autoencoder is composed by two main parts: the encoder and the decoder.
In our case, the encoder is a convolutional neural network (CNN) and the decoder a
recurrent neural network (RNN).
2.4 Convolutional neural networks
CNNs are a category of neural networks that have been proven very effective in areas
such as image recognition and classification [11, 12], but, since they are able to detect
patterns between adjacent parts of the input, they are also useful when working with
text [13].
A CNN is composed by one or more convolutional layers. Each layer has many
feature detectors (also known as kernels), small data structures of 1, 2 or 3 dimensions
depending on the problem. The output of each of these layers is the result of the dot
product between the kernel and each patch of the input (as shown in Figure 2.5).
Convolutional layers have a small amount of parameters compared with the fully-
connected ones, but perform more operations.
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Figure 2.5: Example of a dot product operation between a kernel
and a patch of an image (or any 2-dimensional input). Source: Deep
Learning – Computer Vision and Convolutional Neural Networks
Figure 2.6: Example of a Max Pooling layer of size 2x2 applied to a
4x4 input. Source: ComputerScienceWiki
Mathematically, and for a 2-dimensional case, given a convolution kernel K rep-
resented by a (M ×N) array, the convolution of an image I with K is:





K(m,n)I(x− n, y −m) (2.3)
It is very common, after some convolutional layers, to reduce the size of the output,
either by adding pooling layers or by adding a stride in the convolution operation. A
pooling layer of (M ×N) outputs a single value for every window of (M ×N) in the
input (see Figure 2.6), and adding a stride of N in the convolution makes the kernel
k to jump N positions instead of 1 while doing the convolution.
By doing this, the kernels of the convolutional layers in subsequent steps will
extract different features, usually more generic or related to the whole input instead
of just a little section. Another benefit is that the representation becomes more
invariant to small transitions of the input, this is, that if we translate the input by a
small amount, the values of most of the pooled outputs do not change.
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Figure 2.7: Each rectangle is a vector and arrows represent functions
(e.g. dot product). Input vectors are in red, output vectors are in blue
and green vectors hold the RNN’s state
2.5 Recurrent neural networks
Classical neural networks, including convolutional ones, suffer from two severe limita-
tions: They only accept a fixed-sized vector as input and produce a fixed-sized vector
as output, and they do not consider the sequential nature of some data.
RNNs overcome these limitations by allowing to operate over sequences of vectors
in the input, in the output, or both (Figure 2.7). They have proved to be very effective
in the field of language [14], video frames [15] and time series [16], among others.
The basic formulas for a RNN are:
st = tanh(Uxt +Wst−1) (2.4)
yt = V st (2.5)
These equations basically say that the current network state st commonly known
as hidden state, is a function of the previous hidden state st−1 and the current input
xt. U , V , W matrices are the parameters of the RNN and yt is its output at time t.
The visual concept is shown in Figure 2.8.
Given an input sequence, we apply RNN formulas in a recurrent way until we
process all the input elements. This is what is called "unrolling in time of a RNN".
The RNN shares the parameters U , V , W across all recurrent steps. Some important
observations:
• We can think of the hidden state as a memory of the network that captures
information about the previous steps. It embeds the representation of the se-
quence.
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Figure 2.8: Representation of a RNN unit
Figure 2.9: Complete sequence after unrolling many RNN units
• The output of the network can be considered at every stage (many to many) or
only at the final one (many to one) as shown in Figure 2.7.
• When starting to train a RNN we must provide initial values for U , V , W as
well as for s.
The output y is the probability distribution over the vocabulary (this is, all possible
values) at each time-step t.
Training a RNN is similar to training a traditional NN, but with some modifica-
tions. The main reason is that parameters are shared by all time steps: in order to
compute the gradient at t = 4, we need to propagate 3 steps and sum up the gradients.
This is called backpropagation through time (BPTT).
Recurrent neural networks propagate weight matrices from one time-step to the
next. Recall the goal of a RNN implementation is to enable propagating context
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information through faraway time-steps. When this propagation results in a long
series of matrix multiplications, weights can vanish or explode. We can mitigate
these problems by using gradient clipping [17] or initialising the weights with random
orthogonal matrices.
RNNs work just fine when we are dealing with short-term dependencies. However,
vanilla RNNs fail to understand the long-term context dependencies (when relevant
information may be separated from the point where it is needed by a huge load of
irrelevant data). Gated RNNs (with units that are designed to forget and to update
relevant information) are a solution to this problem.
There are two main types of gated RNNs: Long Short Term Memories (LTSM)
[18] and Gated Recurrent Units (GRU) [19]. In our project, we will use GRUs.
2.5.1 Gated recurrent units
Gated recurrent units are designed in a manner to have more persistent memory
thereby making it easier for RNNs to capture long-term dependencies. Let us define
some new elements and how a GRU uses ht−1 and x to generate the next hidden state
ht.
Update gate : zt = σ(Wz · [xt, ht−1]) (2.6)
Reset gate : rt = σ(Wr · [xt, ht−1]) (2.7)
Newmemory : h̃t = tanh(rt · [xt, rt · ht−1]) (2.8)
Hidden state : ht = (1− zt) · ht−1 + zt · h̃t (2.9)
It combines the forget and input gates into a single “update gate”. It also merges
the cell state and hidden state, and makes some other changes. In general, GRUs are
simpler than LSTMs, faster and optimise quicker.
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Figure 2.10: Architecture of a GRU unit
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Chapter 3
State of the art
The field of de novo molecule generation has been widely studied [4, 5, 6, 7, 8, 9]. While
we have the CC signatures to use as properties of the molecules, other researchers have
used different properties, such as logP or cell-based transcriptional assays [20].
3.1 Deep Autoencoder RNNs with Generative Topographic
Mapping
Some studies can be found in the field of de novo molecule generation. In their work,
Sattarov et al. [9] did an autoencoder with Generative Topographic Mapping (GTM).
From their study it can be highlighted that not only they mention variational autoen-
coders, but also provide the reasons why to not use them for molecule generation. The
reason they provide is that the "property-molecule" relation is "one-to-many" (this
is, the same property can be possessed by very similar molecules), which results in
multimodal distributions of the molecules possessing the desired properties. On the
other hand, a VAE approximates any point distribution by a single gaussian function,
which implies the unimodality of that distribution and creates a contradiction with
the first statement.
GTM is a technique for dimensionality reduction and data visualisation based on
variational Bayesian statistics [21] [22]. As they claim in Sattarov et al. [9], GTM can
be successfully used to approximate multimodal distributions, which is very important
for performing de novo molecular design.
The architecture of they implement is shown in Figure 3.1. As we can see, the
encoder consists of two bidirectional LSTM layers and a Dense layer that has as input
the concatenation of the final cell states and hidden states from both LSTM. The
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Figure 3.1: Architecture of the model developed by Sattarov et al.
[9]
decoder, on the other hand, is composed by 4 parallel Dense layers that form the
initial cell and hidden states for each unidirectional LSTM layer of the decoder.
3.2 Generative Adversarial Autoencoder
Nowadays, almost all the deep learning generative models are VAEs or generative
adversarial networks (GAN). GANs are a type of generative neural network that
differs with the variational autoencoder in the fact that, while the former generates
samples by creating a representation space that follows a gaussian distribution, the
latter trains a separate network that discriminates between the generated samples. In
other words, GANs have a generator, and a discriminator.
In Kadurin el at. [8], they have implemented an adversarial autoencoder (AAE).
It is a derivation of the GAN and, as it is shown in Figure 3.2, it has many similarities
with a variational autoencoder. We can also see that the AAE has an additional
loss compared to the variational autoencoder: the discriminator loss. This loss is
distinguishing between latent variables and the standard gaussian.
As for the results, they claim 3 advantages of the AAE compared to the VAE:
• Adjustability in generating molecular fingerprints.
• Capacity of processing very large molecular datasets.
• Efficiency in unsupervised pretraining for regression model.
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Figure 3.2: Comparison between the architecture of a VAE and an





In order to implement the VAE and the CVAE, we considered two options: Tensorflow1
and Keras2.
The first one is an open source software library for numerical computation using
data flows graphs. Nodes in the graph represent mathematical operations, while
the graph edges represent the multidimensional data array (tensors) communicated
between them3.
The second one is a framework built on top of Tensorflow that provides an abstrac-
tion for many tasks and makes the implementation of neural networks much simpler.
On the other hand, it does not provide as much control as Tensorflow.
Tensorflow, on the other hand, has recently released the 2.0 beta version (July
2019) that includes some Keras functionalities, such as the layers and optimsers. Since
we were already very confident with Keras, we wanted to use it instead of trying a
new framework in which we were not as confident. In future projects, we will consider
using pure Tensorflow as main framework.
4.2 Molecular representation & data preprocessing
As we already know, we are going to use a String representation of a molecule
(SMILES) as input data. But we need to transform this string into something that the
network can understand, this is, real numbers. In order to do so, we first map every
possible character that a SMILES can have into a number. Afterwards, a padding
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Figure 4.1: Example of the one-hot encoding technique applied to
an example SMILES. As we can see, the SMILES is filled up with
white spaces until it is 120 characters long, and then each of them is
converted to an array of size 58, with all zeros except a one in the
position specified by the "character-index" dictionary.
long. Once the size of the string is normalised we use the one-hot encoding technique,
this is, we change every character of the SMILES for its corresponding number in the
dictionary we previously stored and then we turn every number into a sparse vector
of size 58, with all zeros except a one in the position of the corresponding number (see
Figure 4.1).
4.3 HPC
In order to train the models, we got access to a cluster in the Barcelona Supercom-
puting Center (BSC). More concretely, to the CTE-POWER servers, that has clusters
with 4 Tesla V100 GPUs and 160 CPUs. The specifications for each computer node
are as follows4:
• 2 x IBM Power9 8335-GTH@ 2.4GHz (3.0GHz on turbo, 20 cores and 4 threads/core,
total 160 threads per node)
• 512GB of main memory distributed in 16 dimms x 32GB @ 2666MHz
• 2 x SSD 1.9TB as local storage
4Source: BSC
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• 2 x 3.2TB NVME
• 4 x GPU NVIDIA V100 (Volta) with 16GB HBM2.
• Single Port Mellanox EDR
• GPFS via one fiber link 10 GBit
The clusters provide the necessary modules to cover almost all the needs. In our
case, we only needed to load a few modules, like the tensorflow and the rdkit ones.
Since they force you to use at least 40 CPUs for each GPU you use (to avoid
bottlenecks), we implemented the preprocessing using the python’s multithreading
package. By doing this, we take advantage of the multiple cores and we cut the
preprocessing time by a factor of 35.
We trained in parallel several models using 40 CPUs and one GPU. To send
jobs to the cluster, we used the Slurm Workload Manager. According to the Slurm
documentation5, Slurm is an open source, fault-tolerant, and highly scalable cluster
management and job scheduling system for large and small Linux clusters. Slurm
requires no kernel modifications for its operation and is relatively self-contained.
By using the SBATCH directive in an executable file, it is possible to specify many
options for the job, like its name, the number of CPUs to use, the number of GPUs,






5.1 First approach: VAE
The first model we used was a variational autoencoder we found in an internet article1.
It consists of three 1-D convolutional layers as an encoder and 3 GRUs followed by a
TimeDistributed layer, as we can see in Figure 5.1. The author trained the model with
the ChEMBL database2, which is a manually curated chemical database of bioactive
molecules with drug-like properties. More specifically, he used a 80/20 train/test split,
with 99% of the database, since he excluded molecules that have a SMILES larger
than 120 characters.
The main purpose of this model is to learn the grammar of the SMILES. This
means, to be able to represent the SMILES in a low-dimensional vector (latent space)
to reconstruct it later.
The weights of the trained model were provided by the author, so no training was
required in this approach.
The experiments done with this model consist of two main parts:
• First, we pass a set of molecules of size m through the encoder to get their latent
representations.
• Second, since the latent space follows a gaussian distribution, we can sample
using the latent space as the mean and adding a small noise (standard deviation).
We generate n samples from each latent vector.
Since we are encoding m molecules, and trying to reconstruct each one n times, we
are generating m×n potential new molecules. Also, we perform these reconstructions
1Source: Using autoencoders for molecule generation
2https://www.ebi.ac.uk/chembl/
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Figure 5.1: Architecture of the grammarVAE model
for 3 different noises applied to the latent space, more specifically, 0, 0.05 and 0.1
standard deviations.
The molecules used for the prediction were extracted from the DrugBank database3.
Since the experiment takes time, and we wanted this step of the project to be fast, we
split the experiment in two parts: Instead of reconstructing 1,000 molecules (m) 1,000
times (n), we did the experiment for m = 1000, n = 100 and m = 100, n = 1000.
With the first experiment we focused on the behaviour of the reconstructions with
respect to the input molecules, and with the second one we focused on the behaviour
of the reconstructions itself. For the sake of simplicity, and since the data we use is
from the same dataset, we will show the plots from both experiments as if it was only
one, using the plots that are more convenient for each situation.
5.1.1 Results
For this experiment, most of the SMILES were between 20 and 80 characters long
(Figure 5.2), and the most common characters are ’C’ and ’c’, which correspond
to the carbon atom, being the second one a special case for aromatic rings (see
https://en.wikipedia.org/wiki/Aromaticity) (Figure 5.3).
3https://www.drugbank.ca/
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Figure 5.2: Distribution of SMILES length
Figure 5.3: Distribution of SMILES characters
Chapter 5. Development and results 22
(a) Ratio of valid molecules (b) Tanimoto similarity of the reconstruc-tions
Figure 5.4: On the left, the ratio of reconstructed molecules that are
valid. On the right, the Tanimoto similarity between the reconstructed
valid molecules and their original molecule.
In Figure 5.4a we can see the ratio of valid reconstructions. It is very sparse in
the case of 0 noise, but as long as the standard deviation is increased, we can see that
the ratio goes down, meaning that most of the molecules we are generating are not
valid molecules. On the other hand, Figure 5.4b shows that the Tanimoto similarity4
for valid reconstructions also decreases as the standard deviation is increased.
Furthermore, as shown in Figure 5.5, some characters in the input SMILES are
more likely to be correctly reconstructed than others. There is also a clear pattern
between the size of the input length and the ratio of valid reconstructions. As shown
in Figure 5.6, the model performs better when it comes to short SMILES, which
makes sense, since big molecules are more complex and for instance more difficult to
be represented in the latent space without any loss.
So far, it looks like the best option is to not add noise to the reconstructions.
But there is an important fact we are missing here: we are not checking how many
reconstructions are unique. If we have a 100% accuracy in the molecule reconstruction,
but all of them are equal, in the end we are failing in two things: The amount of
different molecules we are generating is less, and the diversity is null. The main goal
is to generate new molecules that are somehow different to the input ones, so having
0 diversity does not help at all.
In Figure 5.7a we can see that the percentage of unique molecules in the 0-noise
case is really low (around 1.5%), but by adding noise with a standard deviation of 0.05
we get around 12% of unique valid molecules. In Figure 5.7b we removed the "unique
valid molecules" bar, so it is easier to see the other bars. The first one represents the
4Tanimoto similarity
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Figure 5.5: Valid reconstructions for every character
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Figure 5.6: Valid reconstructions based on SMILES length
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(a) Length variation for valid reconstruc-
tions
(b) Length variation for valid reconstruc-
tions
amount of molecules that are in UniChem5. This means that those molecules that we
generated are molecules that are registered in a database, which means that they are
valid and/or useful. In order to check that these molecules are not due to overfitting,
we check how many of these molecules are not in ChEMBL, the database that was
used to train the model.
5.2 Second approach: CVAE
In this approach we implemented a conditional variational autoencoder. This means
that this time we will be able to provide additional information to the autoencoder,
in particular the properties of the molecule, which is a vector of 128 dimensions. As
we can see in Figure 5.8, the signature is repeated and concatenated vertically to the
molecule input (one-hot encoded matrix of dimensions 120x58). After the encoder is
applied and we get the latent space, we concatenate the same signature again into
that latent space. Then, we apply the decoder normally.
To train the model, we were provided with 500k molecules from the laboratory’s
database, with their corresponding signatures (more specifically, signature type 3 B4).
The model was trained with 400k molecules in a high performance cluster (details in
section 4.3), using 20% of the data as validation data. After a few hundred epochs,
we got a validation accuracy of 99.5%.
The model was trained applying the categorical cross-entropy loss function at the
reconstruction, and the Kullback-Leibler divergence at the latent space. The learning
rate used was 10−4. We also tried a value of 10−5, but the only difference was the speed
of convergence (the first one converged faster). Since all fine-tuning modifications were
5ebi.ac.uk/unichem
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Figure 5.8: Architecture of the customised conditional variational
autoencoder. The encoder and decoder have the same architecture as
in the VAE. The only difference remains in the input. Note that the
latent space (blue rectangle) is the same for both the output of the
encoder and the input of the encoder.
achieving an accuracy of 99.5%, we used the default learning rate, which achieved the
convergence faster (10−4).
In the experiments done with this model, we will show some plots that are the same
as the ones made for the VAE, but we will omit other plots, like length and character
distribution, or how the reconstructions behave in terms of length or validity for every
character. Instead, we will show some new plots, specially in the second experiment.
5.2.1 First experiment: Fix the signature
In the first experiment, we got a set of 1,000 molecules that were not part of the
training, and encoded them with their respective signatures in order to get their la-
tent space. Once we had 1000 latent spaces, we added noise with different standard
deviations, exactly in the same way we did in the experiments with the VAE, gener-
ating 1,000 copies of each latent space. After that, we concatenated each latent space
with their respective signatures again, and got the reconstructed molecules (1 million
in total).
As we can see in Figure 5.9a, the standard deviation is highly affecting the ratio
of valid molecules we get after decoding. Almost all molecules generated with std = 0
are valid molecules, and almost any molecule generated with std = 0.1 is valid. As
shown in Figure 5.9b, the Tanimoto similarity between the generated molecules and
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(a) Ratio of valid molecules (b) Tanimoto similarity of the reconstruc-tions
Figure 5.9: On the left, the ratio of reconstructed molecules that are
valid. On the right, the Tanimoto similarity between the reconstructed
valid molecules and their input molecule.
Figure 5.10: Proportion of valid and unique molecules for the first
CVAE experiment.
their respective input is also heavily affected by the standard deviation, being the case
of std = 0 not a good choice, since what we want is to generate new molecules that
are slightly different, but not as different as using std = 0.1. Moreover, as shown in
Figure 5.10, the optimal standard deviation to apply to the latent space in order to
maximise the number of unique valid molecules is std = 0.05.
Taking all this considerations, we conclude that the optimal standard deviation in
order to generate a decent amount of somehow similar molecules is 0.05. We will use
this value to apply noise to all latent spaces in the next experiment.
5.2.2 Second experiment: Sample different signatures
This experiment differs from the last one in the sense that instead of just applying
noise to the latent space and generate new molecules (which is what we have been
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Figure 5.11: Proportion of valid and unique reconstructed molecules
for the second CVAE experiment.
doing until now), we will apply a fixed noise of std = 0.05 (which showed a better
performance), and then we will sample different signatures that will be appended to
the latent space. The motivation of this experiment is that we want to check if, after
the molecules are decoded, they preserve the properties of the signatures sampled
from the dataset. If we manage to do so, it means that we are able to generate new
molecules from a molecule M0 with properties S0, that accomplishes different target
properties from the sampled signatures S1, S2, ..., Sn.
For the experiment, we will get a set of 1,000 molecules that were not part of the
training set, and encode them with their respective signatures to get their latent space.
Once we have the latent spaces, we sample for each one a set of 1,000 signatures that
are very similar to the original one, 1,000 signatures that are very different, and 1,000
signatures that are neither similar or different (we called them neutral). In order to
do this sampling, we compute the cosine similarity between the signature of the input
molecule and all the signatures in the dataset.
One we have the 3,000 signatures (1,000 of each group) we proceed to perform
the decoding from the latent space (plus the new sampled signatures) to the new
molecules.
First, let’s analyse the ratio of unique molecules that we have generated. As we
can see in Figure 5.11, the total amount of unique molecules does not increase that
much if we use similar signatures at decoding time. This can mean that the signature
is not affecting very much the prediction, fact that will be denied in posterior plots
(Figure 5.14b).
In Figure 5.12a we can see the distribution of the similarities of the generated
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(a) Tanimoto similarity of ALL the recon-
structions
(b) Tanimoto similarity of the reconstruc-
tions of VALID molecules
Figure 5.12: On the left, the Tanimoto similarity between the recon-
structed valid molecules and their respective input. On the right, the
same comparison but only taking into account unique valid molecules,
this is, removing the repeated reconstructions.
Figure 5.13: Ratio of valid reconstructions based on 3 different levels
of signature similarity.
molecules with respect to the input ones. The peak at similarity 1 is because all those
generated molecules are basically the same as the input. This is due to the nature of
a regular autoencoder: they try to reconstruct the input with the maximum accuracy
possible. After removing the duplicated molecules, we plotted a second distribution
of the similarities taking into account the unique set of molecules (Figure 5.12b). It
does not show a clear difference between the reconstructions from signatures similar
or different to the input molecule.
Regarding the ratio of valid reconstructions (Figure 5.13), we can see again that
the type of signature chosen for the reconstruction does not affect very much the ratio.
There is a slight increase in the ratio for the reconstructions where signatures similar
to the input molecule were used, but it is not very significant.
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(a) Cosine similarity between signatures
of predicted molecules and input signa-
tures
(b) Cosine similarity between signatures
of predicted molecules and the signatures
sampled for the decoding.
Figure 5.14
Up to this point, we saw that the signatures used in the decoding are not affecting
very much the result, but there is still something we have to check. We have to check
if the signatures used at decoding time are affecting the signatures of the predicted
molecules. In order to check this, we compute the signatures of the predicted molecules
using the Chemical Checker module, and we compare it with the signature of the
molecule that was used as input (Figure 5.14a) and with the signatures that were
sampled at decoding time (Figure 5.14b).
As we can see in Figure 5.14a, similarity between the predicted signatures of the
reconstructed molecules and the signature of their corresponding input molecule does
not change based on the type of signature chosen for the decoding.
On the other hand, it does affect when we compare those signatures of predicted
molecules with the corresponding signature used for the decoding (Figure 5.14b). A
perfect plot here would show all the distributions having all the area as close as possible
to 1. This would mean that, no matter the type of signature used for decoding, the
signature of the generated molecule would resemble the signature used to create that
molecule. It makes sense though, that signatures that are very different from the
original one will create a conflict in the network and the generated molecule will not
have a very similar signature. This is due to the fact that when we train the network,
the signature provided to the input and to the latent space resembles the properties of
that molecule, and we are now changing the signature we add to the latent space for
properties that have nothing to do with the molecule. Basically, what Figure 5.14b is
saying, is that it is harder to generate new molecules with properties very different to
the original one (yet possible). On the other hand, using very similar signatures give
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us new molecules that are probably not very similar to the original one (see Tanimoto





There are two main factors that limited the growth of this project: Time and field
knowledge. The lack of time made us go straight to the point and and prevented us
from trying other procedures. Regarding field knowledge, the lack of a specialised
background in biology/chemistry meant investing more time in learning basic con-
cepts, and also limited our perspective of the global problem and hence our ability to
propose new ideas that are only possible with that base knowledge.
Ideas for future studies and implementations that can be improved have been
thought:
• First, when one-hot encoding the SMILES, something we realised is that some
atomic symbols are composed by two characters (i.e. Cl for Chlorine). Despite
the network should be able to recognise these patterns (due to the nature of
CNNs and RNNs), we think it could be a good idea to encode those atomic
symbols as if they were only one character.
• For the last experiment, we could check if the generated molecules that have the
properties of interest belong to some well-known molecule database. By doing
this, we could know if the generated molecules are actually useful or not.
• Another suggestion is to check that the properties of the generated molecules
are closer to the target signature than the signature of the original input. By
doing this, we could measure how the original molecule affects to the inference
of new properties.
• We had an ambitious idea which we already knew it was going to be hard to
perform. GANs are a well known generative network [4] [5] [7] [8], but they are
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extremely difficult to train1. For this reason, we had them at the very end of
our to-do list, but we also think that it is worth to take a look and try to train
one.




This Master’s Thesis was composed of two main parts: The development of a VAE,
and the development of a CVAE. In the first one, we analysed the state-of-the art
regarding to de novo molecule generation using VAEs and we implemented an already-
existing model1 as a first approach. Since the model was already trained, we focused
on exploring the results obtained with new molecules and learned how an autoencoder
works.
Many tests were made with this first model. We tested how the noise in the latent
space affects the quality of the generated molecules, and used this information in the
last experiment of the second approach.
With the second model, the CVAE, we modified the architecture of the previous
VAE and added the CC signature of the molecule to the model. In order to do this,
we looked at simple examples of CVAEs and adapted them to our current VAE23.
After that, we trained the model in a High Performance Cluster with 400k molecules
and their corresponding signatures until we got 99.5% accuracy in the reconstructions.
Then, we performed two main tests: In the first one, we checked again how adding
noise to the latent space affects the generated molecules, and in the second one we
sampled target signatures of interest and changed them in the input of the decoder.
With the second experiment, we saw that our model was able to generate new
molecules with signatures that were close to the target ones. These experiments open
a new opportunity for research in future projects with the help of the signatures from
the CC or any other embedding representation of the properties of a molecule.
1Source: Using autoencoders for molecule generation
2Conditional Variational Autoencoders
3Conditional generation via Bayesian optimisation in latent space
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